Detail akcie Elanc Animl Hlth Rg online

Business Summary: Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Elanco Animal Health Inc revenues increased 2% to $2.43B. Net income totaled $78M vs. loss of $18M. Revenues reflect Pet Health segment increase of 5% to $1.28B, Contract Manufacturing segment increase of 29% to $27M, United States segment increase of 7% to $1.15B. Net Income reflects Asset impairment decrease from $61M (expense) to $0K, Severance and other costs decrease of 98% to $1M (expense).